TokenPost·

Liquidia Sets 2028 PH-ILD Goal, 2029 L606 NDA Submission Target

Your call?

Liquidia Corporation plans to complete PH-ILD enrollment in 2028 and has a 2029 target for an L606 new drug application submission.

Share

More news